Recent advances in buccal drug delivery and absorption — in vitro and in vivo studies
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 62 (1-2) , 149-159
- https://doi.org/10.1016/s0168-3659(99)00032-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sustained-release buccal dosage forms for nitroglycerin and isosorbide dinitrate: increased bioavailability and extended time of absorption when administered to dogsJournal of Controlled Release, 1997
- Buccal delivery of fluorescein isothiocyanate-dextran 4400 and the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigsJournal of Controlled Release, 1996
- In-vivo Buccal Delivery of Fluorescein Isothiocyanate–Dextran 4400 with Glycodeoxycholate as an Absorption Enhancer in PigsJournal of Pharmaceutical Sciences, 1996
- Controlled buccal delivery of buprenorphineJournal of Controlled Release, 1993
- Comparison of the effects of various transmucosal absorption promoters on buccal insulin deliveryInternational Journal of Pharmaceutics, 1989
- The effect of bile salts on the oral mucosal absorption of human calcitonin in rats.Journal of Pharmacobio-Dynamics, 1989
- The effect of additives on the oral mucosal absorption of human calcitonin in rats.Journal of Pharmacobio-Dynamics, 1988
- Adhesive topical drug delivery systemJournal of Controlled Release, 1985
- Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and Carbopol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- New mucosal dosage form of insulin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981